|
Aastrom Biosciences, Inc. - Comparative Business Analysis Snapshot
Business Description
Aastrom Biosciences, Inc.. The Group's principal activity is to develop autologous cell products for use in regenerative medicine. Its proprietary Tissue Repair Cell (TRC) technology is based on its cell products which are unique cell mixture containing increased numbers of stem and early progenitor cells, produced from a small amount of bone marrow taken from the patient. The Group intends to pursue TRC-based cell products for the following therapeutic areas: Cardiac tissue regeneration, Vascular tissue regeneration, Bone tissue regeneration and Neural tissue regeneration. The Group has developed a patented manufacturing system to produce human cells for clinical use. This automated cell manufacturing system enables its "single-pass perfusion" cell culture process. The Group operates in the United States, Germany and Spain. It is in the development stage.
Competitor Analysis
This analysis compares Aastrom Biosciences, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
